Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q1-2022 Pharmacy & Infusion Services Update

Skip to the end of the Expertise Menu

Q1-2022 Pharmacy & Infusion Services Update

Following the formation of several new platform investments in the infusion space, Q1 2022 marked a continuation in deal activity across both add-ons and new platforms. Notable add-on transactions included the acquisition of NBN Infusions by PromptCare (backed by Waud Capital) and Wasatch Infusion by Option Care Health. On the platform side, Ridgemont Equity Partners recapitalized specialty infusion provider American Outcomes Management.

This heightened deal volume creates meaningful opportunity for organizations seeking outside capital to fund growth initiatives and/or realize owner liquidity as the number of acquirers with significant capital resources at their disposal continues to grow. Provident expects deal volumes to persist into Q2 2022 and beyond.

To print and download the full Pharmacy & Infusion Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2022/04/Q1-2022-Pharmacy-Infusion.pdf” link=”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]

 

Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.